v3.25.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Product Revenue
Product Cost of Sales
Gross Income
Administrative Expenses 894,297 1,020,312 1,735,982 2,088,632
Research and Development Expenses 873,472 401,104 2,418,985 1,600,042
Stock Based Compensation Expenses 104,854 439,627 189,490 956,992
Series F-1 Warrant Issuance Expenses 539,097 539,097
Series G Warrant Issuance Expenses 969,505 969,505
Loss from Operations (1,872,623) (3,369,645) (4,344,457) (6,154,268)
Other (Income)/Expenses        
Interest and Dividend Income (57,575) (21,148) (120,087) (39,454)
(Gain)/Loss on Sale of Marketable Securities 75 (2,176) (100)
Change in fair value of Marketable Securities 147 76 1,744 975
Change in fair value of Derivatives Liabilities (19,000) 72,000 (1,303,000) 11,000
Change in fair value of Warrant Liabilities (2,701,000) 4,393,000
Loss on issuance of Series F-1 Convertible Preferred Stock 3,737,000 3,737,000
Loss on issuance of Series G Convertible Preferred Stock 5,109,000 5,109,000
Total Other (Income)/Expense (76,428) 6,196,003 (1,423,519) 13,211,421
Loss Before Income Tax (1,796,195) (9,565,648) (2,920,938) (19,365,689)
Income Tax Benefit
Net Loss (1,796,195) (9,565,648) (2,920,938) (19,365,689)
Preferred Stock Dividends 976,369 777,340 1,789,865 1,979,207
Net Loss Attributable to Common Stockholders $ (2,772,564) $ (10,342,988) $ (4,710,803) $ (21,344,896)
Basic loss per common share $ (0.18) $ (4.54) $ (0.45) $ (9.58)
Diluted loss per common share $ (0.18) $ (4.54) $ (0.45) $ (9.58)
Weighted average basic common stock outstanding 15,698,856 2,275,699 10,552,848 2,228,218
Weighted average diluted common stock outstanding 15,698,856 2,275,699 10,552,848 2,228,218

Source